Here are five things to know:
1. The company made several key acquisitions last year. The Sage Products acquisition contributed $258 million to the net sales while Physio-Control acquisition contributed $740 million.
2. Net earnings for the full year were $1.6 million, up from $1.4 million in 2015. Gross profit hit $7.4 million, a 13.5 percent increase over 2015.
3. Stryker’s orthopedics net sales jumped 4.7 percent in 2016 to $4.4 billion. Medsurg net sales hit $4.9 billion, a 25.6 percent increase. Neurotechnology and spine net sales jumped 9.9 for the full year, hitting $2 billion.
4. The company expects organic sales to grow 5.5 percent to 6.5 percent in 2017 with adjusted net earnings per diluted share to hit $1.40 to $1.45 in the first quarter and $6.35 to $6.45 in the full year.
5. Stryker adopted the updated accounting guidance from the ASU 2016-09 Stock Compensation and estimates if the company share price remains at current levels and stock option exercises remain at historic levels there will be a change in accounting for excess tax benefits on stock compensation that will positively impact net earnings per diluted share by around $0.07 to $0.09 for the full year.
More articles on orthopedic devices:
Zimmer Biomet, Implanet, Spinal Elements & more: 8 device company key notes
SpineFrontier improves MISquito Percutaneous Pedicle Screw System: 7 key points
Orthofix reports final resolution to SEC investigations: 6 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
